| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025253392 |
| P356 | DOI | 10.1038/LABINVEST.3780275 |
| P698 | PubMed publication ID | 11351038 |
| P5875 | ResearchGate publication ID | 232751163 |
| P2093 | author name string | Durand P | |
| Prost M | |||
| Blache D | |||
| Lussier-Cacan S | |||
| Loreau N | |||
| P2860 | cites work | Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers | Q74351414 |
| Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention | Q74505462 | ||
| Homocysteine, vitamins, and cardiovascular disease | Q77066221 | ||
| Evidence for heme-mediated redox regulation of human cystathionine beta-synthase activity | Q77300083 | ||
| Folate deficiencies and cardiovascular pathologies | Q77327391 | ||
| Purification of soluble cytochrome b5 as a component of the reductive activation of porcine methionine synthase | Q77333090 | ||
| Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults | Q77500831 | ||
| Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans | Q78253221 | ||
| Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study | Q93908866 | ||
| Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease | Q104026483 | ||
| Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria | Q24317481 | ||
| A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 | ||
| Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine | Q24563588 | ||
| Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats | Q28252733 | ||
| Homocysteine and cardiovascular disease | Q28265188 | ||
| Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status | Q28273212 | ||
| Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes | Q28297991 | ||
| Cobalamin-dependent methionine synthase | Q28299448 | ||
| Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells | Q28378757 | ||
| Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia | Q28591362 | ||
| Homocysteine inhibits inactivation of factor Va by activated protein C. | Q31574546 | ||
| Homocysteine and hypomethylation. A novel link to vascular disease | Q33586213 | ||
| Oxidant stress: the role of nutrients in cell-lipoprotein interactions. | Q33798862 | ||
| Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging | Q33866127 | ||
| Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism | Q33902343 | ||
| Consequences of homocysteine export and oxidation in the vascular system | Q34049285 | ||
| Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy | Q34049331 | ||
| Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides | Q73958827 | ||
| Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis | Q73964049 | ||
| Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation | Q73964082 | ||
| Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease | Q74302891 | ||
| Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study | Q44836422 | ||
| Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine | Q44881627 | ||
| Functions of glutathione and glutathione disulfide in immunology and immunopathology. | Q45106858 | ||
| Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease | Q45153613 | ||
| Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status | Q45199521 | ||
| High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. | Q45871654 | ||
| Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels | Q45889252 | ||
| Redox regulation of NF-kappa B activation | Q46098446 | ||
| Effective homocysteine metabolism may protect South African blacks against coronary heart disease. | Q46368909 | ||
| Growth promotion by homocysteine but not by homocysteic acid: a role for excessive growth in homocystinuria or proliferation in hyperhomocysteinemia? | Q47928626 | ||
| Oral folate enhances endothelial function in hyperhomocysteinaemic subjects | Q49076386 | ||
| N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. | Q50886303 | ||
| Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. | Q50909239 | ||
| Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. | Q50926553 | ||
| Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. | Q50927274 | ||
| Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. | Q50954984 | ||
| Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. | Q50970547 | ||
| Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. | Q51004854 | ||
| Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. | Q51016678 | ||
| Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. | Q51035720 | ||
| Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. | Q51037949 | ||
| Fluctuations in dietary methionine intake do not alter plasma homocysteine concentration in healthy men. | Q51552976 | ||
| The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. | Q51553967 | ||
| Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. | Q51554245 | ||
| Sex-related differences in methionine metabolism and plasma homocysteine concentrations. | Q51555480 | ||
| Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. | Q51557331 | ||
| Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. | Q51558185 | ||
| Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. | Q51559556 | ||
| Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements | Q34049336 | ||
| Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine | Q34213851 | ||
| The importance of proteins in defense against oxidation. | Q34276279 | ||
| Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study | Q34288393 | ||
| Methionine metabolism in mammals | Q34366989 | ||
| Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease | Q34463309 | ||
| Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. | Q34732901 | ||
| Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group | Q34745701 | ||
| The pathogenesis of coronary artery disease. A possible role for methionine metabolism | Q35200217 | ||
| Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis | Q35571273 | ||
| Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor | Q35612116 | ||
| Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease | Q35706295 | ||
| Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen | Q35824103 | ||
| Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis | Q35904374 | ||
| The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine | Q36731236 | ||
| Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism | Q37271062 | ||
| Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia | Q37356860 | ||
| The effect of a subnormal vitamin B-6 status on homocysteine metabolism | Q37357164 | ||
| Toxicity of thiols and disulphides: involvement of free-radical species | Q38765355 | ||
| Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells | Q40304955 | ||
| Vitamin nutrition status and homocysteine: an atherogenic risk factor | Q40591626 | ||
| Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. | Q40618193 | ||
| Homocyst(e)ine and arterial occlusive diseases | Q40649186 | ||
| Homocysteine metabolism and the oxidative modification of proteins and lipids | Q40823011 | ||
| Cardiovascular disorders (risk assessment). | Q40826158 | ||
| The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes | Q40847581 | ||
| Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease | Q40861331 | ||
| Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. | Q40894125 | ||
| Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism | Q40899870 | ||
| Homocysteine and vascular dysfunction. | Q40911244 | ||
| Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study | Q40916177 | ||
| Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system | Q40945471 | ||
| Antioxidant and redox regulation of gene transcription | Q40989720 | ||
| Vitamins as homocysteine-lowering agents | Q40994205 | ||
| Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis | Q40994217 | ||
| Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine | Q41041293 | ||
| Biological chemistry of thiols in the vasculature and in vascular-related disease | Q41214068 | ||
| Structural requirements for oxidation of low-density lipoprotein by thiols | Q41336275 | ||
| An essential role for free radicals and derived species in signal transduction. | Q41353458 | ||
| Disorders of homocysteine metabolism | Q41521452 | ||
| The case for mild hyperhomocysteinaemia as a risk factor | Q41521469 | ||
| Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism | Q41829734 | ||
| Characterization of the stress-inducing effects of homocysteine | Q42159238 | ||
| The oxidant stress of hyperhomocyst(e)inemia | Q42357039 | ||
| Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading | Q42442785 | ||
| Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study | Q43537322 | ||
| Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study | Q43843769 | ||
| Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. | Q44040534 | ||
| Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis | Q44045023 | ||
| Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? | Q44092957 | ||
| Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria | Q44250339 | ||
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins | Q44610145 | ||
| Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study. | Q51561691 | ||
| Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. | Q51563585 | ||
| Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease. | Q51563589 | ||
| Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. | Q51564806 | ||
| Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. | Q51564872 | ||
| Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. | Q51568729 | ||
| A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. | Q51571427 | ||
| Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. | Q51574125 | ||
| The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. | Q51574356 | ||
| Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. | Q51574876 | ||
| Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. | Q51578946 | ||
| Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. | Q51580787 | ||
| Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. | Q51583985 | ||
| Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. | Q51584078 | ||
| Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. | Q51584611 | ||
| Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. | Q51587739 | ||
| Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? | Q51589418 | ||
| Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. | Q51590314 | ||
| Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. | Q51590957 | ||
| Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. | Q51593043 | ||
| Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. | Q51713940 | ||
| Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. | Q52524806 | ||
| Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. | Q52529329 | ||
| Thiyl radical attack on polyunsaturated fatty acids: a possible route to lipid peroxidation. | Q53038543 | ||
| Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. | Q53749113 | ||
| Homocysteine accelerates endothelial cell senescence. | Q53793755 | ||
| Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. | Q54082540 | ||
| Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications. | Q54097159 | ||
| Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys. | Q54151583 | ||
| Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. | Q54178663 | ||
| Serum Folate and Risk of Fatal Coronary Heart Disease | Q56171251 | ||
| A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease | Q57268055 | ||
| Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis | Q57746092 | ||
| Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women | Q57751240 | ||
| What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L | Q58771545 | ||
| Dietary Folate from Vegetables and Citrus Fruit Decreases Plasma Homocysteine Concentrations in Humans in a Dietary Controlled Trial | Q63694115 | ||
| Lipid peroxidation in homocysteinaemia | Q67560177 | ||
| Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors | Q68120400 | ||
| Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis | Q68886315 | ||
| Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 | ||
| Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor | Q70457039 | ||
| Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study | Q70633264 | ||
| Serum total homocysteine and coronary heart disease | Q70870288 | ||
| Homocysteine and vascular disease | Q70992813 | ||
| Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation | Q71168973 | ||
| Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury | Q71282008 | ||
| Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine | Q71434913 | ||
| Hyperhomocysteinemia induced by folic acid deficiency and methionine load--applications of a modified HPLC method | Q71548994 | ||
| Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism | Q71611634 | ||
| Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study | Q71691429 | ||
| Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation | Q71745443 | ||
| Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians | Q71785109 | ||
| Homocysteine increases cyclin-dependent kinase in aortic rat tissue | Q71785173 | ||
| Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease | Q71807467 | ||
| Lipid peroxidation and homocysteine induced toxicity | Q71993516 | ||
| Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits | Q72028521 | ||
| Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study | Q72030504 | ||
| Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease | Q72049325 | ||
| Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients | Q72110083 | ||
| A prospective study of plasma homocyst(e)ine and risk of ischemic stroke | Q72202573 | ||
| Local and systemic effects of cigarette smoking on folate and vitamin B-12 | Q72204323 | ||
| Redox status and protein binding of plasma homocysteine and other aminothiols in patients with hyperhomocysteinemia due to cobalamin deficiency | Q72263568 | ||
| Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men | Q72282317 | ||
| Vitamin status and intake as primary determinants of homocysteinemia in an elderly population | Q72305071 | ||
| Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol | Q72501650 | ||
| Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations | Q72533017 | ||
| Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria | Q72583869 | ||
| Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects | Q72880046 | ||
| Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells | Q72908761 | ||
| Cysteine is a cardiovascular risk factor in hyperlipidemic patients | Q72992389 | ||
| Adaptation and survival of surface-deprived red blood cells in mice | Q72996652 | ||
| Influence of homocysteine on matrix metalloproteinase-2: activation and activity | Q73004122 | ||
| Plasma homocysteine and cardiovascular disease mortality | Q73073921 | ||
| Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women | Q73152917 | ||
| The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis | Q73176788 | ||
| Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients | Q73176797 | ||
| Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects | Q73257371 | ||
| Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats | Q73284474 | ||
| Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids | Q73284482 | ||
| Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia | Q73310526 | ||
| Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation | Q73413911 | ||
| Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions | Q73435152 | ||
| Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase | Q73456320 | ||
| Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading | Q73484126 | ||
| Plasma homocysteine levels and mortality in patients with coronary artery disease | Q73520715 | ||
| Evaluation of the Abbott IMx fluorescence polarization immunoassay and the bio-rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography | Q73588775 | ||
| Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine | Q73704318 | ||
| Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine | Q73735641 | ||
| Blood glutathione and cysteine changes in cardiovascular disease | Q73792879 | ||
| Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans | Q73825799 | ||
| Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity | Q73832886 | ||
| Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial | Q73832888 | ||
| Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells | Q73832931 | ||
| Optimization of routine plasma homocysteine monitoring | Q73880746 | ||
| Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes | Q73935045 | ||
| Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells | Q73937050 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 645-672 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Impaired homocysteine metabolism and atherothrombotic disease | |
| P478 | volume | 81 |
| Q43187581 | Asymptomatic Mongolian middle-aged women with high homocysteine blood level and atherosclerotic disease |
| Q26822655 | Atherosclerosis: process, indicators, risk factors and new hopes |
| Q46268537 | B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia |
| Q33634614 | Calorie restriction in mammals and simple model organisms. |
| Q46969684 | Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients |
| Q44092042 | Coagulation parameters and plasma total homocysteine levels in Behcet's disease |
| Q36385381 | Cystathionine β-synthase regulates endothelial function via protein S-sulfhydration |
| Q35600410 | DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations |
| Q64245371 | Depression, Hematologic Parameters, and Blood Levels of Vitamin B12 in Patients With Laryngopharyngeal Reflux Under Use of Proton Pump Inhibitors |
| Q30756538 | Development of hydrophilic fluorogenic derivatization reagents for thiols: 4-(N-acetylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole and 4-(N-trichloroacetylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole |
| Q45171661 | Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system. |
| Q45191286 | Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. |
| Q43985968 | Dynamics of the enzymatic antioxidants during experimental caprine coccidiosis |
| Q59034818 | Effect of polyunsaturated fatty acids on homocysteine metabolism through regulating the gene expressions involved in methionine metabolism |
| Q37252186 | Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients |
| Q28395558 | Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health |
| Q43784576 | Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells |
| Q28645810 | Folate: a key to optimizing health and reducing disease risk in the elderly |
| Q46746325 | Forty percent and eighty percent methionine restriction decrease mitochondrial ROS generation and oxidative stress in rat liver. |
| Q46406762 | Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years |
| Q37502883 | Garlic: nature's protection against physiological threats |
| Q50883662 | Higher homocysteine and lower betaine increase the risk of microangiopathy in patients with diabetes mellitus carrying the GG genotype of PEMT G774C. |
| Q44825250 | Homocysteine and neuropsychiatric disorders |
| Q37624240 | Homocysteine and the C677T Gene Polymorphism of Its Key Metabolic Enzyme MTHFR Are Risk Factors of Early Renal Damage in Hypertension in a Chinese Han Population |
| Q37347147 | Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. |
| Q44131619 | Homocysteine in neuropsychiatric disorders of the elderly |
| Q35803548 | Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress |
| Q40443287 | Homocysteine inhibits store-mediated calcium entry in human endothelial cells: evidence for involvement of membrane potential and actin cytoskeleton |
| Q37444674 | Homocysteine is associated with plasma high-sensitivity cardiac troponin T levels in a community-dwelling population |
| Q90419442 | Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort |
| Q37079207 | Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation |
| Q44430794 | Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine |
| Q37231486 | Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk |
| Q44441377 | Homocysteine, Methylenetetrahydrofolate Reductase C677T Polymorphism and the B-Vitamins: A Facet of Nature-Nurture Interplay |
| Q92112512 | Homocysteinemia as a cause for amaurosis fugax in a patient without an apparent embolic source |
| Q92403305 | Hydroxymethylglutaryl Coenzyme a Reductase Inhibitors Differentially Modulate Plasma Fatty Acids in Rats With Diet-Induced-Hyperhomocysteinemia: Is ω-3 Fatty Acids Supplementation Necessary? |
| Q43273808 | Hyperhomocysteinemia and cardiometabolic risk |
| Q44481626 | Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients |
| Q82425115 | Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis |
| Q44249469 | Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans--causes and implications |
| Q43232061 | Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications |
| Q44185515 | Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats |
| Q44429121 | Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats |
| Q87156835 | Hyperhomocysteinemia regulated SCF expression in cultured cardiomyocytes via modulation of NF-κB activities |
| Q34333986 | Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects |
| Q36517333 | Leukocyte Telomere Length is Associated With Serum Vitamin B12 and Homocysteine Levels in Older Adults With the Presence of Systemic Inflammation |
| Q40495672 | Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease |
| Q44673201 | Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease |
| Q28077202 | Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q49060165 | Methionine and homocysteine modulate the rate of ROS generation of isolated mitochondria in vitro. |
| Q44593201 | Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease |
| Q48209997 | Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients |
| Q37274442 | Molecular mechanisms of adaptation to folate deficiency |
| Q45204055 | No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans |
| Q44517339 | Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment |
| Q48101614 | Paraoxonases: metabolic role and pharmacological projection. |
| Q46922662 | Plasma homocysteine and severe white matter disease |
| Q36272176 | Protein and lipid oxidative damage and complex I content are lower in the brain of budgerigar and canaries than in mice. Relation to aging rate |
| Q45068677 | Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis |
| Q24793107 | Risk factors in coronary atherosclerosis athero-inflammation: the meeting point |
| Q28073469 | Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance |
| Q35144189 | Serum homocysteine and folate levels in korean schizophrenic patients |
| Q44637427 | Serum homocysteine level is higher in Behçet’s disease with vascular involvement |
| Q64257173 | The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art |
| Q33616058 | The Prevalence of Hypertension Accompanied by High Homocysteine and its Risk Factors in a Rural Population: A Cross-Sectional Study from Northeast China |
| Q34390949 | The atherogenic effect of excess methionine intake |
| Q34606409 | The glutamate agonist homocysteine sulfinic acid stimulates glucose uptake through the calcium-dependent AMPK-p38 MAPK-protein kinase C zeta pathway in skeletal muscle cells |
| Q37630461 | Transsulfuration Is a Significant Source of Sulfur for Glutathione Production in Human Mammary Epithelial Cells |
| Q30999497 | What explains the increased rate of thromboses among the elderly? Pathophysiological data |
Search more.